Literature DB >> 18209681

Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge.

Sarah Benki1, Sara B Mostad, Barbra A Richardson, Kishorchandra Mandaliya, Joan K Kreiss, Julie Overbaugh.   

Abstract

Levels of HIV-1 RNA in endocervical specimens fluctuate with the menstrual cycle, suggesting that cell-free HIV-1 levels may vary during the cycle, which could influence infectivity. Here, we examined daily changes in endocervical HIV-1-infected cells during 1 cycle. There were significant positive associations between the number of days from the luteinizing hormone surge and the number of HIV-1 DNA copies/swab (P = 0.001) and the number of total cells/swab (P < 0.001) in endocervical specimens. These data suggest that sampling of cell-associated endocervical HIV-1 increases after the periovulatory period, which could result in increased exposure to HIV-1-infected cells during sexual contact.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209681      PMCID: PMC3412868          DOI: 10.1097/QAI.0b013e318165b952

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  12 in total

1.  The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions.

Authors:  Patricia S Reichelderfer; Andrea Kovacs; David J Wright; Alan Landay; Susan Cu-Uvin; David N Burns; Jonathan Cohn; Robert W Coombs
Journal:  J Infect Dis       Date:  2002-09-01       Impact factor: 5.226

2.  The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions.

Authors:  Julie M Villanueva; Tedd V Ellerbrock; Jeffrey L Lennox; Timothy J Bush; Thomas C Wright; Melody Pratt-Palmore; Tammy Evans-Strickfaden; Lois J Conley; Cathy Schnell; Clyde E Hart
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

3.  Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters.

Authors:  Sarah Benki; R Scott McClelland; Sandra Emery; Jared M Baeten; Barbra A Richardson; Ludo Lavreys; Kishorchandra Mandaliya; Julie Overbaugh
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

4.  Mucosal shedding of human herpesvirus 8 in men.

Authors:  J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

5.  Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission.

Authors:  Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

6.  Human immunodeficiency virus in plasma and genital secretions during the menstrual cycle.

Authors:  C Goulston; E Stevens; D Gallo; J I Mullins; C V Hanson; D Katzenstein
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

7.  Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle.

Authors:  S B Mostad; S Jackson; J Overbaugh; M Reilly; B Chohan; K Mandaliya; P Nyange; J Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

8.  Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.

Authors:  Ruth E Tuomala; Peter T O'Driscoll; James W Bremer; Cheryl Jennings; Chong Xu; Jennifer S Read; Elaine Matzen; Alan Landay; Carmen Zorrilla; William Blattner; Manhattan Charurat; Deborah J Anderson
Journal:  J Infect Dis       Date:  2003-01-24       Impact factor: 5.226

9.  Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus.

Authors:  Deborah M Money; Yasmin Y Arikan; Valencia Remple; Chris Sherlock; Kevin Craib; Patricia Birch; David R Burdge
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

10.  Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle.

Authors:  Sarah Benki; Sara B Mostad; Barbra A Richardson; Kishorchandra Mandaliya; Joan K Kreiss; Julie Overbaugh
Journal:  J Infect Dis       Date:  2004-05-24       Impact factor: 5.226

View more
  7 in total

Review 1.  Characteristics and quantities of HIV host cells in human genital tract secretions.

Authors:  Joseph A Politch; Jai Marathe; Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

2.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

3.  Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.

Authors:  Mimi Ghosh; Zheng Shen; John V Fahey; Susan Cu-Uvin; Kenneth Mayer; Charles R Wira
Journal:  Immunology       Date:  2009-07-18       Impact factor: 7.397

Review 4.  Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens.

Authors:  Charles R Wira; John V Fahey; Marta Rodriguez-Garcia; Zheng Shen; Mickey V Patel
Journal:  Am J Reprod Immunol       Date:  2014-04-16       Impact factor: 3.886

5.  Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.

Authors:  Patricia Kissinger; Angela Amedee; Rebecca A Clark; Jeanne Dumestre; Katherine P Theall; Leann Myers; Michael E Hagensee; Thomas A Farley; David H Martin
Journal:  Sex Transm Dis       Date:  2009-01       Impact factor: 2.830

6.  Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection.

Authors:  Marta Rodriguez-Garcia; Nabanita Biswas; Mickey V Patel; Fiona D Barr; Sarah G Crist; Christina Ochsenbauer; John V Fahey; Charles R Wira
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

7.  miRNA profiling of primate cervicovaginal lavage and extracellular vesicles reveals miR-186-5p as a potential antiretroviral factor in macrophages.

Authors:  Zezhou Zhao; Dillon C Muth; Kathleen Mulka; Zhaohao Liao; Bonita H Powell; Grace V Hancock; Kelly A Metcalf Pate; Kenneth W Witwer
Journal:  FEBS Open Bio       Date:  2020-09-11       Impact factor: 2.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.